1. Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study. Issue 10373 (28th January 2023) Authors: Verstovsek, Srdan; Gerds, Aaron T; Vannucchi, Alessandro M; Al-Ali, Haifa Kathrin; Lavie, David; Kuykendall, Andrew T; Grosicki, Sebastian; Iurlo, Alessandra; Goh, Yeow Tee; Lazaroiu, Mihaela C; Egyed, Miklos; Fox, Maria Laura; McLornan, Donal; Perkins, Andrew; Yoon, Sung-Soo; Gupta, Vikas; Kilad... Journal: Lancet Issue: Volume 401:Issue 10373(2023) Page Start: 269 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Population pharmacokinetics and Bayesian estimators for intravenous mycophenolate mofetil in haematopoietic stem cell transplant patients. Issue 8 (28th February 2020) Authors: Labriffe, Marc; Vaidie, Julien; Monchaud, Caroline; Debord, Jean; Turlure, Pascal; Girault, Stephane; Marquet, Pierre; Woillard, Jean‐Baptiste Journal: British journal of clinical pharmacology Issue: Volume 86:Issue 8(2020) Page Start: 1550 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗